131 results
8-K
EX-99.1
NVTAQ
Invitae Corp
6 Mar 24
Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
8:31am
apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream
8-K
EX-99.1
NVTAQ
Invitae Corp
14 Feb 24
Entry into a Material Definitive Agreement
6:59am
as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
To learn
8-K
EX-99.1
NVTAQ
Invitae Corp
22 Jan 24
Invitae Completes Sale of Reproductive Health Assets to Natera
7:05am
. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic
8-K
EX-99.1
NVTAQ
Invitae Corp
14 Dec 23
Cost Associated with Exit or Disposal Activities
4:29pm
and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive
8-K
EX-99.1
mwriny4knd7lgn
8 Nov 23
Invitae Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
00qkg0yplx
22 Sep 23
Invitae Receives Notice of Non-Compliance with NYSE
5:02pm
8-K
EX-99.1
yttpeu bknc675y2cj
8 Aug 23
Invitae Reports Second Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
8wuqsi5mmmcs6h16cfs
9 May 23
Invitae Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
vuyk9iz9e7v7aojfh
20 Dec 22
Other Events
9:00am
8-K
EX-99.1
a15wx 6evqd4x
8 Nov 22
Invitae Reports Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
kzz4az9os3me
9 Aug 22
Invitae Reports $136.6 Million in Revenue in Second Quarter of 2022
12:00am
8-K
EX-99.1
zpa69
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
8-K
EX-99.3
n1at6
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm